News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Michele Bevere: Novel Role of the MAPK Signalling Pathway in Pancreatic Cancer
Michele Bevere/researchgate.net
Dec 6, 2024, 19:59

Michele Bevere: Novel Role of the MAPK Signalling Pathway in Pancreatic Cancer

Michele Bevere, AIRC Postdoctoral Fellow at University of Verona, shared an article by Lisa Veghini on X:

“We described a novel role of the MAPK signaling pathway in shaping CAF phenotype in Pancreatic Cancer, providing new insights into tumor-stromal cell interactions.”

Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.

Authors: Lisa Veghini, et al.

Michele Bevere: Novel Role of the MAPK Signalling Pathway in Pancreatic Cancer

AIRC CAF phenotype cancer fight against cancer Global fight against cancer Lisa Veghini MAPK Michele Bevere OncoDaily Oncology Pancreatic Cancer Scarpa's lab Università di Verona
Special Coverage
Insight
Dec 6, 2024, 19:59
Michele Bevere: Novel Role of the MAPK Signalling Pathway in Pancreatic Cancer
Insight
Dec 6, 2024, 18:58
Commemorating the 30th Anniversary of Childhood Cancer International
Blog
Dec 6, 2024, 18:54
Estela Rodriguez: Great evening of community and learning from patients living with lung cancer
Blog
Dec 6, 2024, 18:51
Drew Moghanaki: Happiness is being mentored by the Dean of the UCLA School of Medicine to think even bigger
Blog
Dec 6, 2024, 18:47
Break Through Cancer - Launching the PoweRD 2 Cure ALK+ Lung Cancer TeamLab
Blog
Dec 6, 2024, 18:44
Jennifer Douglas: Getting Into The Daily Radiation Routine
Blog
Dec 6, 2024, 18:41
Michelle Mitchell OBE: Celebrating the Impact of CRUK Volunteers in Beating Cancer
Blog
Dec 6, 2024, 18:38
AACR-JCA Joint Conference: From Cancer Discovery Science to Therapeutic Innovation
Blog
Dec 6, 2024, 18:33
AstraZeneca’s Imfinzi has been approved in the US for the treatment of adult patients with limited-stage SCLC
Blog
Dec 6, 2024, 18:10
Emad Shash: Teamwork Makes the Dream Work
Insight
Dec 6, 2024, 17:29
Prevention and screening efforts in the past 45 years - NCI
Insight
Dec 6, 2024, 17:13
Guilherme Nader Marta: RWE is becoming increasingly vital in cancer research